English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aim of this study is to determine the prevalence of extended spectrum  beta-lactamase (ESBL) producing Klebsiella pneumoniae strains isolated from  blood in children and their susceptibility to antimicrobial drugs commonly  used in the therapy. The study was conducted at the Institute of Public  Health of Vojvodina Province, Serbia, in a two-year period, from January 2009  to December 2010. A total of 424 non-duplicate strains were isolated from the  blood of pediatric patients hospitalized in various wards in the Institute of  Health Care of Children and Youth of Vojvodina Province. Fifty isolates of  Klebsiella pneumoniae were reported. The frequency of isolation of Klebsiella  pneumoniae was 27/222 (12.2%) and 23/202 (11.3%) isolates in 2009 and 2010,  respectively. There was a high prevalence of ESBL-producing Klebsiella  pneumoniae, 76% (38/50), and 17 isolates (44.7%) were multidrug resistant  (MDR). Further drug resistance surveillance in hospitals and the molecular  characterization of ESBL-positive isolates in our country is necessary

Bloodstream infections in children caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae